CD90 expression has been found to be elevated in hepatic stem/progenitor cells (262) and was associated with the malignant and differentiated phenotype of HCC cells in tumors (263) and a poor survival rate in HCC patients (264–266). Here, THY1 is linked to hepatocellular carcinoma.